Value in Thrombosis Management Advances in Anticoagulant Therapy to Support Primary PCI   Anticoagulation in ACS: Emerging Therapeutic Options Cancer Support Innovations Extending Erythropoietic Stimulating Protein Dosing in Chemotherapy-Induced Anemia Contemporary Heart Failure Management A Closer Look at Mortality ADHF, Nesiritide and Renal Failure Expert Panel Recommendations   Additional UPA Resources: USP Chapter 797: Compounding Sterile Preparations - Q and A     Publications      Anemia Integrating Recent Growth Factor Evidence, Practice Guidelines and FDA Recommendations: Validating the Pharmacist's Role in Management Contemporary Growth Factor Management: Three Institutional Perspectives Optimizing Erythropoietic Growth Factor Formulary Management: Interchange Opportunities Inpatient Darbepoetin Alfa: Conversions, Costs, and Critical Use Erythropoietic Growth Factors in Oncology-Associated Anemia Part 1: Molecules to Formulary Developing Guidelines for Treating Cancer-Related Anemia      Antithrombotics   Anticoagulation in Non-ST-Segment Elevation Acute Coronary Syndromes (NSTE ACS): Emerging Therapeutic Options Consensus on Contemporary Issues with Unfractionated Heparin: Challenges in Variation and Responsiveness Applying Scientific Criteria to Therapeutic Interchange: A Balanced Analysis of Low-Molecular Weight Heparins Anticoagulant bridging: Prosthetic heart valves, labeling changes, and limiting issues of liability Can Lytic Outcomes in MI Be Further Optimized with LMWHs? Combination antithrombotic therapy in acute myocardial infarction Low-Molecular-Weight Heparins: Formulary Drug Class Review Pharmacologic and Liability Considerations of Therapeutic Interchange with Low-Molecular-Weight Heparins Venous Thromboembolism Prevention with LMWHs in Medical and Orthopedic Surgery Patients      Chemotherapy-Induced Nausea and Vomiting Pharmacoeconomic Analysis of Palonosetron in Patients Receiving Moderately Emetogenic Chemotherapy (Presented at the 2004 ASHP Midyear Meeting) Abstract, Poster Prevention of Chemotherapy-Induced Nausea and Vomiting: The Economic Implications of Choosing Antiemetics      Fibrinolytics Horizons in Antithrombosis - February 2005 Newsletter Can Lytic Outcomes in MI Be Further Optimized with LMWHs? Cathflo monograph Tenecteplase: Innovative Fibrinolysis for ST-Segment Elevation Myocardial Infarction (STEMI) Tenecteplase (TNK) Monograph       Sepsis Drotrecogin alfa (activated) Guidelines Drotrecogin alfa (activated) Drug Use Evaluation Implementing Guidelines for Drotrecogin Alfa (activated): Three Perspectives Innovation in Sepsis Management Patient Selection Guidelines and DUE for Drotrecogin Alfa (activated) Note: You will need Adobe Acrobat reader in order to view the above newsletters. Click the icon to the left to download.